VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
88,334
AK1,815
AL6,133
AR3,993
AS45
AZ14,539
CA64,759
CO12,159
CT8,719
DC1,747
DE1,868
FL41,499
FM3
GA16,132
GU92
HI2,477
IA4,739
ID2,763
IL21,496
IN23,655
KS4,844
KY8,414
LA5,328
MA15,281
MD13,105
ME3,277
MH8
MI20,143
MN12,873
MO10,275
MP30
MS3,073
MT2,392
NC17,450
ND1,440
NE3,023
NH3,124
NJ19,456
NM4,089
NV4,600
NY36,525
OH20,140
OK6,525
OR8,918
PA24,920
PR2,483
QM2
RI2,092
SC6,952
SD1,243
TN10,038
TX38,745
UT4,482
VA15,477
VI62
VT1,780
WA15,487
WI11,573
WV2,461
WY894
XB5
XL1
XV2

ID: 1177831
Sex: U
Age:
State: IN

Vax Date:
Onset Date: 03/20/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: EXTREME/EXCRUCIATING PAIN; SLEEPING 20 HOURS A DAY; EXTREME TIREDNESS; This spontaneous report received from a patient concerned a 47 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included psoriatic arthritis, and spondylosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: Unknown) dose was not reported, administered on 20-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 20-MAR-2021, the subject experienced extreme/excruciating pain. On 20-MAR-2021, the subject experienced sleeping 20 hours a day. On 20-MAR-2021, the subject experienced extreme tiredness. Treatment medications (dates unspecified) included: alprazolam, and hydrocodone bitartrate/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extreme/excruciating pain on 20-MAR-2021, had not recovered from extreme tiredness, and the outcome of sleeping 20 hours a day was not reported. This report was non-serious.

Other Meds:

Current Illness: Psoriatic arthritis; Spondylosis

ID: 1177832
Sex: M
Age:
State: AZ

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SORE ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included ulcerative colitis.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included vedolizumab for ulcerative colitis. On MAR-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.

Other Meds: ENTYVIO

Current Illness: Ulcerative colitis

ID: 1177833
Sex: F
Age:
State: MA

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ACHES/PAIN; STOMACH ISSUES; HIGH FEVER; EXHAUSTION; TURNED HER ALLERGY WORSE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced aches/pain, stomach issues, high fever, exhaustion, and turned her allergy worse. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from aches/pain, stomach issues, high fever, exhaustion, and turned her allergy worse. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177834
Sex: U
Age:
State:

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: CHEST PAIN; CHILLS; ARM SORE; ACHY MUSCLES; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case No concomitant medications were reported. On MAR-2021, the subject experienced chest pain. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced arm sore. On MAR-2021, the subject experienced achy muscles. On MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102. The action taken with covid-19 vaccine was not applicable. The patient recovered from fever on 29-MAR-2021, and the outcome of achy muscles, chest pain, chills and arm sore was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177835
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 03/24/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: TINGLING IN LEFT AND RIGHT ARMS AND FINGERS; FEVER; PAIN AT INJECTION SITE; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included surgery in left arm. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered to left arm on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-MAR-2021, the subject experienced fever. On 24-MAR-2021, the subject experienced chills. On 24-MAR-2021, the subject experienced pain at injection site. On 27-MAR-2021, the subject experienced tingling in arms and fingers. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, chills, and pain at injection site on 26-MAR-2021, and had not recovered from tingling in arms and fingers. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177836
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 03/27/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: HEART RACING; FELT LIKE ADRENALINE RUSH; SKIN TINGLING; GOOSEBUMPS; TROUBLE SLEEPING; LOW ENERGY; This spontaneous report received from a patient concerned a 52 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021, vaccinated to left arm for prophylactic vaccination. No concomitant medications were reported. On 27-MAR-2021 (Saturday), the patient experienced low energy. On 28-MAR-2021, the subject experienced heart racing and adrenaline was rush. On 28-MAR-2021, the patient also experienced tingling in her skin, goosebumps, trouble sleeping and heart racing. The patient still having these symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low energy on MAR-2021, and had not recovered from felt like adrenaline rush, skin tingling, goosebumps, trouble sleeping, and heart racing. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious.

Other Meds:

Current Illness:

ID: 1177837
Sex: F
Age:
State: WI

Vax Date:
Onset Date: 03/26/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: MUSCLE ACHES; EXTREME COLD FEELING; FEVER OF 100 F; CHILLS; BODY ACHES; NAUSEA; EXTREME FATIGUE; HEADACHE; This spontaneous report received from a patient concerned a 56 year old female. The patient's height, and weight were not reported. The patient's past medical history included prediabetic but become better with diet and exercise .menopause, and other pre-existing medical conditions included does the patient have any allergies? :: no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 180 8069 expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 26-MAR-2021, the subject experienced body aches. On 26-MAR-2021, the subject experienced nausea. On 26-MAR-2021, the subject experienced extreme fatigue. On 26-MAR-2021, the subject experienced headache. On 27-MAR-2021, the subject experienced chills. On 27-MAR-2021, the subject experienced fever of 100 f. Laboratory data included: Body temperature (NR: not provided) 100 F. On 27-MAR-2021 03:00, the subject experienced extreme cold feeling. On an unspecified date, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, muscle aches, and extreme fatigue on 28-MAR-2021, chills, nausea, headache, and fever of 100 f on 27-MAR-2021, and extreme cold feeling. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177838
Sex: M
Age:
State:

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: DULL HEADACHE; MUSCLE SORENESS AT INJECTION SITE; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced muscle soreness at injection site. On 29-MAR-2021, the subject experienced dull headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from dull headache, and the outcome of muscle soreness at injection site was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177839
Sex: F
Age:
State:

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: FLU LIKE SYMPTOMS FOR 3 DAYS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced flu like symptoms for 3 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms for 3 days on MAR-2021. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177840
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SWELLING; BODY ACHES/PAIN; ARMPIT WAS VERY PAINFUL; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced swelling, body aches/pain, and armpit was very painful. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling, and body aches/pain, and the outcome of armpit was very painful was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177841
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BREATHING GOT WORST; ANKLES SWELLING; HANDS SWELLING; SORE THROAT; TONGUE SORE; FEVER; This spontaneous report received from a patient concerned an elderly female. The patient's height, and weight were not reported. The patient's past medical history included heart attack, and concurrent conditions included copd, bad heart, and pneumonia, and other pre-existing medical conditions included the patient had no history of allergy to vaccine, drug, or food and no past history of similar event.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced ankles swelling. On MAR-2021, the subject experienced hands swelling. On MAR-2021, the subject experienced sore throat. On MAR-2021, the subject experienced tongue sore. On MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F, and Investigation (NR: not provided) UNKNOWN. On 29-MAR-2021, the subject experienced breathing got worst. Laboratory data included: COVID-19 virus test (NR: not provided) Negative. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from breathing got worst, and the outcome of sore throat, ankles swelling, hands swelling, tongue sore and fever was not reported. This report was non-serious.; Sender's Comments: V1: Medical assessment comment not required as per the standard operating procedure as the case is assessed as non-serious.

Other Meds:

Current Illness: Chronic obstructive pulmonary disease; Heart disorder; Pneumonia

ID: 1177842
Sex: F
Age:
State: IL

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BREAST TENDERNESS; NIPPLE TENDERNESS; HOT FLASHES; MENOPAUSE; This spontaneous report received from a patient concerned a 63 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: not reported) dose was not reported, once a total administered on 12-MAR-2021 to left arm as prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced menopause. On 13-MAR-2021, the subject experienced hot flashes. On 25-MAR-2021, the subject experienced breast tenderness. On 25-MAR-2021, the subject experienced nipple tenderness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hot flashes on 16-MAR-2021, had not recovered from breast tenderness, and nipple tenderness, and the outcome of menopause was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177843
Sex: M
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ITCHING; TINGLING IN SKIN; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 21-MAR-2021 for prophylactic vaccination on right arm. No concomitant medications were reported. On an unspecified date, the subject experienced itching, and tingling in skin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the itching and tingling in skin was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177844
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 03/19/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: DOES NOT FEEL VERY WELL; NAUSEA; CHILLS; HEADACHE; LOW FEVER; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included coronary artery disease, non-alcohol user, non-smoker, sulfa allergy, and penicillin allergy, and other pre-existing medical conditions included no drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 19-MAR-2021, the subject experienced chills. On 19-MAR-2021, the subject experienced headache. On 19-MAR-2021, the subject experienced low fever. On 28-MAR-2021, the subject experienced nausea. On 30-MAR-2021, the subject experienced does not feel very well. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on MAR-2021, and low fever on 28-MAR-2021, and had not recovered from headache, nausea, and does not feel very well. This report was non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Allergic reaction to antibiotics; Coronary artery disease; Non-smoker; Penicillin allergy

ID: 1177845
Sex: U
Age:
State: CA

Vax Date:
Onset Date: 03/25/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: VACCINE ADMINISTERED AFTER TEMPERATURE EXCURSION; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: 13-JUN-2021) dose was not reported, administered on 25-MAR-2021, 26-MAR-2021, and 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the patients experienced vaccine administered after temperature excursion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine administered after temperature excursion was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177846
Sex: U
Age:
State:

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SORE; LOSS OF APPETITE; FEELING TERRIBLE; ACHING JOINTS; INCREDIBLE FEVER; TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, once a total administered on 28-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced sore. On MAR-2021, the subject experienced loss of appetite. On MAR-2021, the subject experienced feeling terrible. On MAR-2021, the subject experienced aching joints. On MAR-2021, the subject experienced incredible fever. On MAR-2021, the subject experienced tired. Laboratory data included: Lab test (NR: not provided) 8/10 recommended (units unspecified). The action taken with covid-19 vaccine was not applicable. The outcome of the tired, loss of appetite, incredible fever, aching joints, feeling terrible and sore was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177847
Sex: F
Age:
State: ID

Vax Date:
Onset Date: 03/19/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: EARACHE; SINUS BLOCKAGE; FACIAL PUFFINESS; ITCHY; RASH ON FACE; RED SPOTS ON FACE; NAUSEA; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's past medical history included rosacea, and concurrent conditions included osteoporosis, alcohol use, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received COVID-19 VACCINE ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 at 10:40 to right arm for prophylactic vaccination. No concomitant medications were reported. On 19-MAR-2021, the subject experienced earache. On 19-MAR-2021, the subject experienced sinus blockage. On 19-MAR-2021, the subject experienced facial puffiness. On 19-MAR-2021, the subject experienced itchy. On 19-MAR-2021, the subject experienced rash on face. On 19-MAR-2021, the subject experienced red spots on face. On 19-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from earache, sinus blockage, and nausea on 20-MAR-2021, had not recovered from rash on face, facial puffiness, and red spots on face, and the outcome of itchy was not reported. This report was non-serious.

Other Meds:

Current Illness: Alcohol use (Occasionally(glass of wine once to thrice a month).); Non-smoker; Osteoporosis

ID: 1177848
Sex: F
Age:
State: GA

Vax Date:
Onset Date: 03/27/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: STICKY AND OOZY EYES; HER EYES BECAME BLOOD SHOT; HER EYES BECAME RED; WHITE PATCHES IN MOUTH; VERY SENSITIVE TONGUE/TONGUE WAS VERY SENSITIVE; RUNNING NOSE WITH A CONSTANT NASAL DRIP; FATIGUE; HER EYES BECAME OOZY; SLEPT ALL DAY; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included Sjogren's disease, rheumatoid arthritis, odours,environmental allergies, and had problems with eyes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On 27-MAR-2021, the subject experienced her eyes became oozy. On 27-MAR-2021, the subject experienced slept all day. On 27-MAR-2021, the subject experienced fatigue. On 27-MAR-2021 17:30, the subject experienced running nose with a constant nasal drip. On 29-MAR-2021, the subject experienced very sensitive tongue/tongue was very sensitive. On 30-MAR-2021, the subject experienced white patches in mouth. On an unspecified date, the subject experienced her eyes became blood shot, her eyes became red, and sticky and oozy eyes. Treatment medications (dates unspecified) included: allergy medication. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from her eyes became blood shot, sticky and oozy eyes, her eyes became oozy, and her eyes became red, had not recovered from running nose with a constant nasal drip, fatigue, and white patches in mouth, and the outcome of very sensitive tongue/tongue was very sensitive and slept all day was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious

Other Meds:

Current Illness: Allergy; Eye disorder; Rheumatoid arthritis; Sjogren's disease

ID: 1177849
Sex: F
Age:
State: NJ

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: FEVER; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, once a total administered, on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 106 degrees. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on MAR-2021. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177850
Sex: F
Age:
State: LA

Vax Date:
Onset Date: 03/30/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: CHEST PAIN; BODY ACHES; ITCHING TO ARM AND NECK; DIZZY; VOMITING; NAUSEA; HEADACHE; SWELLING AT INJECTION SITE; This spontaneous report received from a patient concerned a 36 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included antibiotics (unspecified) drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 09:30 on left arm for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced chest pain. On 30-MAR-2021, the subject experienced body aches. On 30-MAR-2021, the subject experienced itching to arm and neck. On 30-MAR-2021, the subject experienced dizzy. On 30-MAR-2021, the subject experienced vomiting. On 30-MAR-2021, the subject experienced nausea. On 30-MAR-2021, the subject experienced headache. On 30-MAR-2021, the subject experienced swelling at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, swelling at injection site, itching to arm and neck, nausea, chest pain, dizzy, body aches and vomiting was not reported. This report was non-serious.

Other Meds:

Current Illness: Allergy to antibiotic

ID: 1177851
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 03/29/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SWELLING OF THE THROAT; HIVES OF THROAT; FEVER; HEADACHE; SHORTNESS OF BREATH; SWEATING; LEFTOVER 6TH DOSE WAS ADMINISTERED TO PATIENT; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 29-MAR-2021 14:00 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JAN-2021, Laboratory data included: COVID-19 virus test positive (NR: not provided) Positive. On MAR-2021, Laboratory data included: Oxygen saturation (NR: not provided) 93. Treatment medications included: acetylsalicylic acid, diphenhydramine hydrochloride, and paracetamol. On 29-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 104 F. On 29-MAR-2021 14:00, the subject experienced leftover 6th dose was administered to subject. On 30-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 102.9 F. On 30-MAR-2021 04:00, the subject experienced shortness of breath. On 30-MAR-2021 04:00, the subject experienced sweating. On 30-MAR-2021 04:00, the subject experienced swelling of the throat. On 30-MAR-2021 04:00, the subject experienced hives of throat. On 30-MAR-2021 04:00, the subject experienced fever. On 30-MAR-2021 04:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling of the throat, and hives of throat on 30-MAR-2021 at around 10:00, was recovering from shortness of breath, had not recovered from headache, fever, and sweating, and the outcome of leftover 6th dose was administered to patient was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious

Other Meds:

Current Illness:

ID: 1177852
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BODYACHE; CHILL; FEVER; HEADACHE; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced bodyache, chill, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chill, headache and bodyache was not reported. This report was non-serious. This case, from the same reporter is linked to 20210359266.

Other Meds:

Current Illness:

ID: 1177853
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SORE ARM; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177854
Sex: F
Age:
State:

Vax Date:
Onset Date: 03/27/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: POPPED A BLOOD VESSEL; BRUISING OF ARM; FLU LIKE SYMPTOMS (FEVER AND BODY ACHES); This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included thyroid issues. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 16:15 on left arm for prophylactic vaccination. No concomitant medications were reported. On 27-MAR-2021, the subject experienced popped a blood vessel. On 27-MAR-2021, the subject experienced bruising of arm. On 27-MAR-2021 at around 2:30, the subject experienced flu like symptoms (fever and body aches). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms (fever and body aches) on 27-MAR-2021 07:30, and the outcome of popped a blood vessel and bruising of arm was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.

Other Meds:

Current Illness: Thyroid disorder

ID: 1177855
Sex: M
Age:
State: SC

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: KNOT ON LEFT ARM; OFF LABEL USE; INAPPROPRIATE ROUTE OF VACCINATION; INCREASED BP; INCREASED HEART RATE; DIZZINESS SUNDAY AND MONDAY; PAIN IN ARM; DONT FEEL WELL; SOME NAUSEA; TINGLING OF HAND; This spontaneous report received from a patient concerned a 42 year old male. The patient's weight was 239 (unit unspecified), and height was 5 (unit unspecified). The patient's concurrent conditions included allergy, thyroid, sinus infection, elevated growth hormone, non-alcoholic, and non-smoker, and other pre-existing medical conditions included the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intravenous, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on left deltoid on 27-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced tingling of hand. On 27-MAR-2021, the subject experienced off label use. On 27-MAR-2021, the subject experienced inappropriate route of vaccination. On 27-MAR-2021, the subject experienced increased blood pressure. On 27-MAR-2021, the subject experienced increased heart rate. On 27-MAR-2021, the subject experienced dizziness Sunday and Monday. On 27-MAR-2021, the subject experienced pain in arm. On 27-MAR-2021, the subject experienced don't feel well. On 27-MAR-2021, the subject experienced some nausea. On 28-MAR-2021, the subject experienced knot on left arm. Laboratory data (dates unspecified) included: EKG (NR: not provided) clear. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness Sunday and Monday, and had not recovered from knot on left arm, tingling of hand, pain in arm, some nausea, increased blood pressure, increased heart rate, don't feel well, inappropriate route of vaccination, and off label use. This report was non-serious.; Sender's Comments: V1: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.

Other Meds:

Current Illness: Abstains from alcohol; Allergy; Growth hormone increased; Non-smoker; Sinus infection (30 days prior to vaccination.); Thyroid disorder

ID: 1177856
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BODY ACHES; CHILLS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and body aches was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177857
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 03/21/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: TESTED POSITIVE FOR COVID-19; This spontaneous report received from a patient concerned a 27 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy to insect bites, and other pre-existing medical conditions included the patient has suspected lupus but not diagnosed. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802072 and expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 21-MAR-2021, the subject experienced tested positive for covid-19. Laboratory data included: Blood pressure (NR: not provided) NORMAL, COVID-19 virus test positive (NR: not provided) POSITIVE, and Oxygen saturation (NR: not provided) NORMAL. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tested positive for covid-19. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case assessed as non-serious.

Other Meds:

Current Illness: Insect bite allergy

ID: 1177858
Sex: F
Age:
State: MI

Vax Date:
Onset Date: 03/27/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BODY ACHES; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; GASSY; SCRATCHY THROAT; JOINT PAIN; FEELING REALLY COLD/ CHILLS; FEVER (100-101.4F); MUSCLE PAIN; NAUSEA; TIRED; HEADACHE; This spontaneous report received from a consumer concerned a 16 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-MAR-2021, the subject experienced body aches. On 27-MAR-2021, the subject experienced product administered to subject of inappropriate age. On 27-MAR-2021, the subject experienced product administered to subject of inappropriate age. On 27-MAR-2021, the subject experienced gassy. On 27-MAR-2021, the subject experienced scratchy throat. On 27-MAR-2021, the subject experienced joint pain. On 27-MAR-2021, the subject experienced feeling really cold/ chills. On 27-MAR-2021, the subject experienced fever (100-101.4f). On 27-MAR-2021, the subject experienced muscle pain. On 27-MAR-2021, the subject experienced nausea. On 27-MAR-2021, the subject experienced tired. On 27-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 100-101.4 F. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling really cold/ chills, fever (100-101.4f), body aches, muscle pain, joint pain, nausea, gassy, tired, and headache, and the outcome of scratchy throat, product administered to patient of inappropriate age and product administered to patient of inappropriate age was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.

Other Meds:

Current Illness:

ID: 1177859
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: VERY SICK; TEMPERATURE OF 102; This spontaneous report received from a patient via a company representative concerned a 19 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case.. No concomitant medications were reported. On an unspecified date, the subject experienced temperature of 102, and very sick. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the temperature of 102 and very sick was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177860
Sex: F
Age:
State: IN

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: CHILLS; This spontaneous report received from a patient concerned a African/American Hispanic/Latino female of an unspecified age. The patient's weight, height, and medical history were not reported. The patient received Covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced chills. The action taken with covid-19 vaccine was not applicable. The outcome of chills was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177861
Sex: U
Age:
State:

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COLD; FEEL KIND OF BAD; SHIVERING; FINGERS HURT; HEAD HURT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced cold. On MAR-2021, the subject experienced feel kind of bad. On MAR-2021, the subject experienced shivering. On MAR-2021, the subject experienced fingers hurt. On MAR-2021, the subject experienced head hurt. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the head hurt, cold, shivering, fingers hurt and feel kind of bad was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177862
Sex: M
Age:
State: NJ

Vax Date:
Onset Date: 03/26/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: HIVES ON EAR AND HEAD; FEVER; This spontaneous report received from a consumer concerned a 70 year old male. The patient's height, and weight were not reported. The patient's past medical history included stroke, and heart problems, and concurrent conditions included penicillin allergy. The patient experienced drug allergy when treated with tramadol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 26-MAR-2021, the subject experienced hives on ear and head. On 26-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hives on ear and head on 28-MAR-2021, and fever on 27-MAR-2021. This report was non-serious.

Other Meds:

Current Illness: Penicillin allergy

ID: 1177863
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of chills was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177864
Sex: M
Age:
State: CA

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BAD FLU-LIKE SYMPTOMS; CHILLS; FEVER; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced bad flu-like symptoms. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine was not applicable. The patient recovered from bad flu-like symptoms, chills, and fever on MAR-2021. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177865
Sex: F
Age:
State: OH

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ELEVATED LIVER ENZYMES; HEADACHE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on MAR-2021 to left deltoid for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced elevated liver enzymes. On MAR-2021, the subject experienced headache. Laboratory data (dates unspecified) included: Elevated liver enzymes (NR: not provided) Liver enzymes elevated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache and elevated liver enzymes was not reported. This report was non-serious. This case, from the same reporter is linked to 20210403235.

Other Meds:

Current Illness:

ID: 1177866
Sex: M
Age:
State: FL

Vax Date:
Onset Date: 03/27/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BURNING SENSATION TO THE LEFT OF THE GROIN AREA AND LEGS; INFLAMED GROIN AREA AND LEGS; This spontaneous report received from a patient concerned a 51 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received COVID-19 vaccine (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 13:00 in left deltoid for prophylactic vaccination. No concomitant medications were reported. On 27-MAR-2021, the patient experienced burning sensation to the left of the groin area and legs. On 27-MAR-2021, the patient experienced inflamed groin area and legs. The action taken with COVID-19 vaccine was not applicable. The patient had not recovered from burning sensation to the left of the groin area and legs and inflamed groin area and legs. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177867
Sex: F
Age: 79
State: OK

Vax Date: 03/12/2021
Onset Date: 03/14/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BODY ACHES; TIREDNESS; This spontaneous report received from a patient concerned a 79 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAR-2021, the subject experienced body aches. On 14-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and tiredness on MAR-2021. This report was non-serious. This case, from the same reporter is linked to 20210356802.

Other Meds:

Current Illness:

ID: 1177868
Sex: M
Age: 51
State: TN

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SLUGGISHNESS; HEAVINESS; PAIN; CHILLS; FEVER; HEADACHES; TIREDNESS; SWEATING; DROWSY; WALKING AROUND LIKE FOG; DID NOT REMEMBER; This spontaneous report received from a patient concerned a 51 year old male. The patient's height, and weight were not reported. The patient's past medical history included normal headache. The patient was previously treated with paracetamol for headache. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 20-MAR-2021 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced walking around like fog. On MAR-2021, the subject experienced did not remember. On 21-MAR-2021, the subject experienced sweating. On 21-MAR-2021, the subject experienced drowsy. On 21-MAR-2021, the subject experienced sluggishness. On 21-MAR-2021, the subject experienced heaviness. On 21-MAR-2021, the subject experienced pain. On 21-MAR-2021, the subject experienced chills. On 21-MAR-2021, the subject experienced fever. On 21-MAR-2021, the subject experienced headaches. On 21-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, drowsy, pain, chills, and fever on 22-MAR-2021, and walking around like fog, sluggishness, heaviness, did not remember, headaches, and tiredness on MAR-2021. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177869
Sex: U
Age:
State:

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: CHILLS; HEADACHES; NAUSEA; INJECTION SITE SORENESS; FATIGUE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported. Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced headaches. On MAR-2021, the subject experienced nausea. On MAR-2021, the subject experienced injection site soreness. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headaches, and the outcome of nausea, chills, injection site soreness and fatigue was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177870
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: MAN SUFFERS RARE SEVERE REACTION TO COVID-19 VACCINE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced man suffers rare severe reaction to covid-19 vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of man suffers rare severe reaction to covid-19 vaccine was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177871
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 03/29/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BODY ACHE; DIZZINESS; GETTING COLDER; SWEATING; CAN'T MOVE LEGS AND INJECTED ARM; HEADACHE; NAUSEA; HIGH FEVER; INJECTION SITE ARM SORENESS; This spontaneous report received from a vaccine facility concerned a 30 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN, expiry: UNKNOWN) dose was not reported, administered on 29-MAR-2021 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 29-MAR-2021, the subject experienced body ache. On 29-MAR-2021, the subject experienced dizziness. On 29-MAR-2021, the subject experienced getting colder. On 29-MAR-2021, the subject experienced sweating. On 29-MAR-2021, the subject experienced can't move legs and injected arm. On 29-MAR-2021, the subject experienced headache. On 29-MAR-2021, the subject experienced nausea. On 29-MAR-2021, the subject experienced high fever. On 29-MAR-2021, the subject experienced injection site arm soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, body ache, dizziness, nausea, high fever, getting colder, sweating, injection site arm soreness, and can't move legs and injected arm. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177872
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ARM WAS SORE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced arm was sore. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm was sore. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177873
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: HIGH BLOOD PRESSURE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch no was not reported. Per-procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced high blood pressure. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) high. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of high blood pressure was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177874
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: LITTLE ACHY; HEADACHE; ARM HURTS A LOT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced little achy, headache, and arm hurts a lot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, arm hurts a lot and little achy was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177875
Sex: U
Age:
State: FL

Vax Date:
Onset Date: 03/29/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 5 PATIENTS GIVEN 0.3ML OF JANSSEN VACCINE (VERSUS THE STANDARD 0.5ML); PARTIAL/ SPLIT DOSING; This spontaneous report received from a health care professional concerned multiple patients of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) 0.3 ml, administered on 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the 5 patients given 0.3ml of janssen vaccine (versus the standard 0.5ml) at three different facilities. On 29-MAR-2021, the patients administered partial/ split dosing. The health care professional stated that they thought that the vaccine was like the another company vaccine and should be given at 0.3ml. The reporter was unable to obtain the information for the five patients. The five patients were in different facilities. The health care professional was unable to give the names but however they recalled the cities with one of the facilities being an institution for homebound patients. The health care professional further mentioned that she was unsure if a sample would still be available as the remaining vials had been turned in at the end of the day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the 5 patients given 0.3ml of janssen vaccine (versus the standard 0.5ml) and partial/ split dosing was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177876
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BODY ACHES; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and fever. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177877
Sex: F
Age:
State: NJ

Vax Date:
Onset Date: 03/22/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SINUS SYMPTOMS; DRYNESS; SORE ARM; This spontaneous report received from a patient concerned a 70 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 22-MAR-2021, the subject experienced sore arm. On 29-MAR-2021, the subject experienced sinus symptoms. On 29-MAR-2021, the subject experienced dryness. The action taken with covid-19 vaccine was not applicable. The patient recovered from sore arm on 30-MAR-2021, and was recovering from sinus symptoms, and dryness. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177878
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: VOMITED; 25 PLUS TIMES DIARRHEA; SEVERELY RUNNY DIARRHEA; CHILLS; ACHY MUSCLES; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. No concomitant medications were reported. On an unspecified date, the subject experienced vomited, 25 plus times diarrhea, severely runny diarrhea, chills, and achy muscles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, achy muscles, vomited, severely runny diarrhea and 25 plus times diarrhea was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177879
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ARM WAS A LITTLE SORE; FEVERISH; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced arm was a little sore, and feverish. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arm was a little sore and feverish was not reported. This report was non-serious.

Other Meds:

Current Illness:

ID: 1177880
Sex: U
Age:
State:

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 04/07/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and fatigue on MAR-2021. This report was non-serious.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 679,999

Page last modified: 03 October 2021 5:28pm